Great West Life Assurance CO Puma Biotechnology, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $5,705 - $13,173	-2,002 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$9.5 - $11.14 $151,791 - $177,994	-15,978 Reduced 88.87%	2,002 $20,000
Q3 2020 Nov 13, 2020	BUY	$9.5 - $11.14 $151,791 - $177,994	15,978 Added 798.1%	17,980 $181,000
Q4 2019 Feb 11, 2020	BUY	$6.5 - $10.73 $13,013 - $21,481	2,002 New	2,002 $17,000
Q3 2019 Oct 25, 2019	SELL	$8.75 - $12.85 $33,022 - $48,495	-3,774 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$93.85 - $132.45 $71,795 - $101,324	765 Added 25.42%	3,774 $372,000
Q3 2017 Nov 09, 2017	BUY	$72.0 - $119.75 $216,648 - $360,327	3,009	3,009 $352,000

100

30.5M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $139M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.